BHAGIRADHA CHEMICALS & INDUSTRI Share Price
Sector: Chemical Manufacturing
You have to be logged in to add this to Watchlist.
Login or Register
312.25 -14.80 (-4.53%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
308
Today’s High
326.7
52 Week Low
116.51
52 Week High
448
310.40 -14.80 (-4.55%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
308
Today’s High
334.55
52 Week Low
137.7
52 Week High
447.7
Key Metrics
- Market Cap (In Cr) 4046.62
- Beta -
- Div. Yield (%) 0.03
- P/B 8.18
- TTM P/E 175.33
- Peg Ratio -14.06
- Sector P/E 24.11
- D/E 0.14
- Open Price 326
- Prev Close 327.05
BHAGIRADHA CHEMICALS & INDUSTRI Analysis
Price Analysis
-
1 Week-2.98%
-
3 Months-15.37%
-
6 Month80.37%
-
YTD111.88%
-
1 Year104.74%
Risk Meter
- 59% Low risk
- 59% Moderate risk
- 59% Balanced Risk
- 59% High risk
- 59% Extreme risk
BHAGIRADHA CHEMICALS & INDUSTRI News
Q3 results this week: L&T Finance, Axis Bank, Yes Bank, Adani Power and more
5 min read . 21 Jan 2024Dividend stocks: IRCTC, Naukri to MRF — 25 stocks to trade ex-dividend today
2 min read . 17 Nov 2023Multibagger chemical stock announces dividend after rallying 260% in 3 years
2 min read . 04 Nov 2022BHAGIRADHA CHEMICALS & INDUSTRI Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 407.65
- Selling/ General/ Admin Expenses Total
- 33.28
- Depreciation/ Amortization
- 10.98
- Other Operating Expenses Total
- 84.83
- Total Operating Expense
- 375.71
- Operating Income
- 31.93
- Net Income Before Taxes
- 26.92
- Net Income
- 18.22
- Diluted Normalized EPS
- 1.61
- Period
- 2024
- Total Assets
- 576.04
- Total Liabilities
- 162.33
- Total Equity
- 413.71
- Tangible Book Valueper Share Common Eq
- 39.54
- Period
- 2024
- Cashfrom Operating Activities
- 34.29
- Cashfrom Investing Activities
- -120.62
- Cashfrom Financing Activities
- 88.31
- Net Changein Cash
- 1.99
- Period
- 2023
- Total Revenue
- 502.09
- Selling/ General/ Admin Expenses Total
- 43.15
- Depreciation/ Amortization
- 9.81
- Other Operating Expenses Total
- 11.97
- Total Operating Expense
- 434.57
- Operating Income
- 67.52
- Net Income Before Taxes
- 63.78
- Net Income
- 45.15
- Diluted Normalized EPS
- 4.44
- Period
- 2023
- Total Assets
- 446.91
- Total Liabilities
- 133.66
- Total Equity
- 313.25
- Tangible Book Valueper Share Common Eq
- 30.06
- Period
- 2023
- Cashfrom Operating Activities
- 13.89
- Cashfrom Investing Activities
- -59.61
- Cashfrom Financing Activities
- 46.47
- Net Changein Cash
- 0.73
- Period
- 2022
- Total Revenue
- 435.67
- Selling/ General/ Admin Expenses Total
- 35.81
- Depreciation/ Amortization
- 8.73
- Other Operating Expenses Total
- 11.24
- Total Operating Expense
- 376.12
- Operating Income
- 59.55
- Net Income Before Taxes
- 51.31
- Net Income
- 35.75
- Diluted Normalized EPS
- 3.77
- Period
- 2022
- Total Assets
- 342.02
- Total Liabilities
- 152.15
- Total Equity
- 189.87
- Tangible Book Valueper Share Common Eq
- 19.97
- Period
- 2022
- Cashfrom Operating Activities
- 6.61
- Cashfrom Investing Activities
- -17.12
- Cashfrom Financing Activities
- 12.42
- Net Changein Cash
- 1.88
- Period
- 2021
- Total Revenue
- 317.9
- Selling/ General/ Admin Expenses Total
- 34.8
- Depreciation/ Amortization
- 8.17
- Other Operating Expenses Total
- 1.92
- Total Operating Expense
- 278.12
- Operating Income
- 39.77
- Net Income Before Taxes
- 32.14
- Net Income
- 23.32
- Diluted Normalized EPS
- 2.38
- Period
- 2021
- Total Assets
- 273.17
- Total Liabilities
- 117.49
- Total Equity
- 155.69
- Tangible Book Valueper Share Common Eq
- 16.37
- Period
- 2021
- Cashfrom Operating Activities
- 3.56
- Cashfrom Investing Activities
- -20.76
- Cashfrom Financing Activities
- 14.8
- Net Changein Cash
- -2.4
- Period
- 2020
- Total Revenue
- 245.67
- Selling/ General/ Admin Expenses Total
- 48.27
- Depreciation/ Amortization
- 6.66
- Other Operating Expenses Total
- 1.54
- Total Operating Expense
- 232.93
- Operating Income
- 12.73
- Net Income Before Taxes
- 8.92
- Net Income
- 6.51
- Diluted Normalized EPS
- 0.5
- Period
- 2020
- Total Assets
- 225.26
- Total Liabilities
- 93.02
- Total Equity
- 132.24
- Tangible Book Valueper Share Common Eq
- 13.89
- Period
- 2020
- Cashfrom Operating Activities
- 48.16
- Cashfrom Investing Activities
- -38.6
- Cashfrom Financing Activities
- -9.12
- Net Changein Cash
- 0.44
- Period
- 2019
- Total Revenue
- 383.98
- Selling/ General/ Admin Expenses Total
- 18.25
- Depreciation/ Amortization
- 4.82
- Other Operating Expenses Total
- 21.87
- Total Operating Expense
- 347.51
- Operating Income
- 36.47
- Net Income Before Taxes
- 29.12
- Net Income
- 18.29
- Diluted Normalized EPS
- 1.93
- Period
- 2019
- Total Assets
- 273.62
- Total Liabilities
- 145.52
- Total Equity
- 128.1
- Tangible Book Valueper Share Common Eq
- 13.45
- Period
- 2019
- Cashfrom Operating Activities
- 48.87
- Cashfrom Investing Activities
- -37.62
- Cashfrom Financing Activities
- -12.38
- Net Changein Cash
- -1.13
- Period
- 2018
- Total Revenue
- 186.73
- Selling/ General/ Admin Expenses Total
- 11.59
- Depreciation/ Amortization
- 2.92
- Other Operating Expenses Total
- 32.29
- Total Operating Expense
- 186.33
- Operating Income
- 0.4
- Net Income Before Taxes
- -5.75
- Net Income
- -1.3
- Diluted Normalized EPS
- 0.55
- Period
- 2018
- Total Assets
- 243.06
- Total Liabilities
- 141.23
- Total Equity
- 101.83
- Tangible Book Valueper Share Common Eq
- 11.4
- Period
- 2018
- Cashfrom Operating Activities
- -26.75
- Cashfrom Investing Activities
- -13.03
- Cashfrom Financing Activities
- 42.54
- Net Changein Cash
- 2.76
- Period
- 2024-09-30
- Total Revenue
- 103.73
- Selling/ General/ Admin Expenses Total
- 10.25
- Depreciation/ Amortization
- 3.41
- Other Operating Expenses Total
- 20.7
- Total Operating Expense
- 97.43
- Operating Income
- 6.3
- Net Income Before Taxes
- 7.78
- Net Income
- 5.44
- Diluted Normalized EPS
- 0.42
- Period
- 2024-09-30
- Total Assets
- 833.36
- Total Liabilities
- 206.35
- Total Equity
- 627.01
- Tangible Book Valueper Share Common Eq
- 50.19
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -34.06
- Cashfrom Investing Activities
- -175.69
- Cashfrom Financing Activities
- 226.24
- Net Changein Cash
- 16.49
- Period
- 2024-06-30
- Total Revenue
- 111.39
- Selling/ General/ Admin Expenses Total
- 9.63
- Depreciation/ Amortization
- 3.25
- Other Operating Expenses Total
- 20.19
- Total Operating Expense
- 102.64
- Operating Income
- 8.75
- Net Income Before Taxes
- 9.67
- Net Income
- 5.71
- Diluted Normalized EPS
- 0.49
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 111.25
- Selling/ General/ Admin Expenses Total
- 8.81
- Depreciation/ Amortization
- 2.85
- Other Operating Expenses Total
- 22.35
- Total Operating Expense
- 100.02
- Operating Income
- 11.23
- Net Income Before Taxes
- 10.56
- Net Income
- 7.22
- Diluted Normalized EPS
- 0.59
- Period
- 2024-03-31
- Total Assets
- 576.04
- Total Liabilities
- 162.33
- Total Equity
- 413.71
- Tangible Book Valueper Share Common Eq
- 39.54
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 34.29
- Cashfrom Investing Activities
- -120.62
- Cashfrom Financing Activities
- 88.31
- Net Changein Cash
- 1.99
- Period
- 2023-12-31
- Total Revenue
- 74.37
- Selling/ General/ Admin Expenses Total
- 8.32
- Depreciation/ Amortization
- 2.68
- Other Operating Expenses Total
- 22.02
- Total Operating Expense
- 68.78
- Operating Income
- 5.59
- Net Income Before Taxes
- 4.79
- Net Income
- 3.32
- Diluted Normalized EPS
- 0.28
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 122.01
- Selling/ General/ Admin Expenses Total
- 8.69
- Depreciation/ Amortization
- 2.81
- Other Operating Expenses Total
- 21
- Total Operating Expense
- 111.37
- Operating Income
- 10.64
- Net Income Before Taxes
- 8.51
- Net Income
- 5.72
- Diluted Normalized EPS
- 0.55
- Period
- 2023-09-30
- Total Assets
- 475.76
- Total Liabilities
- 157.73
- Total Equity
- 318.03
- Tangible Book Valueper Share Common Eq
- 30.51
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 6.06
- Cashfrom Investing Activities
- -33.21
- Cashfrom Financing Activities
- 24.69
- Net Changein Cash
- -2.46
- Period
- 2023-06-30
- Total Revenue
- 100.01
- Selling/ General/ Admin Expenses Total
- 7.46
- Depreciation/ Amortization
- 2.63
- Other Operating Expenses Total
- 19.47
- Total Operating Expense
- 95.54
- Operating Income
- 4.47
- Net Income Before Taxes
- 3.07
- Net Income
- 1.97
- Diluted Normalized EPS
- 0.19
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 122.57
- Selling/ General/ Admin Expenses Total
- 7.87
- Depreciation/ Amortization
- 2.58
- Other Operating Expenses Total
- 20.87
- Total Operating Expense
- 106.93
- Operating Income
- 15.64
- Net Income Before Taxes
- 14.3
- Net Income
- 9.39
- Diluted Normalized EPS
- 0.9
- Period
- 2023-03-31
- Total Assets
- 446.91
- Total Liabilities
- 133.66
- Total Equity
- 313.25
- Tangible Book Valueper Share Common Eq
- 30.06
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 13.89
- Cashfrom Investing Activities
- -59.61
- Cashfrom Financing Activities
- 46.47
- Net Changein Cash
- 0.73
- Period
- 2022-12-31
- Total Revenue
- 126
- Selling/ General/ Admin Expenses Total
- 7.39
- Depreciation/ Amortization
- 2.47
- Other Operating Expenses Total
- 20.7
- Total Operating Expense
- 109.15
- Operating Income
- 16.84
- Net Income Before Taxes
- 16.49
- Net Income
- 11.65
- Diluted Normalized EPS
- 1.12
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
BHAGIRADHA CHEMICALS & INDUSTRI Technical
Moving Average
SMA
- 5 Day325.37
- 10 Day334.56
- 20 Day337.28
- 50 Day352.49
- 100 Day343.88
- 300 Day262.94
BHAGIRADHA CHEMICALS & INDUSTRI Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- NOCIL
- 256.85
- -5.1
- -1.95
- 336.1
- 218
- 4280.41
- Rossari Biotech
- 764
- -12.55
- -1.62
- 966
- 657.8
- 4220.79
- BHAGIRADHA CHEMICALS & INDUSTRI
- 312.25
- -14.8
- -4.53
- 448
- 116.51
- 3249.11
- Fineotex Chemical
- 324.25
- -10.45
- -3.12
- 458
- 305.2
- 3591.55
- India Glycols
- 1112.8
- -29.85
- -2.61
- 1545
- 685
- 3445.4
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- NOCIL
- 36.44
- 2.57
- 9.82
- 10.58
- Rossari Biotech
- 33.23
- 4.1
- 16.03
- 7.66
- BHAGIRADHA CHEMICALS & INDUSTRI
- 202.57
- 8.18
- 12.14
- 6.75
- Fineotex Chemical
- 30.92
- 8.29
- 24.67
- 17.46
- India Glycols
- 20.82
- 1.73
- 10.97
- 2.6
BHAGIRADHA CHEMICALS & INDUSTRI Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 12-Nov-24
- Quarterly Results
- 02-Aug-24
- Quarterly Results
- 24-May-24
- Audited Results, Dividend & A.G.M.
- 05-Mar-24
- Stock Split
- 27-Jan-24
- Quarterly Results
- 17-Nov-23
- Others
- 04-Nov-23
- Quarterly Results
- 11-Oct-23
- Rights issue & Preferential issue
- 04-Aug-23
- Quarterly Results
- 13-May-23
- Audited Results, Final Dividend & A.G.M.
- Meeting Date
- Announced on
- Purpose
- 09-Aug-24
- 27-May-24
- AGM
- 09-Aug-24
- 22-Jun-24
- AGM
- 12-Apr-24
- 05-Mar-24
- POM
- 28-Jan-24
- 27-Dec-23
- POM
- 27-Jan-24
- 26-Dec-23
- POM
- 04-Nov-23
- 13-Oct-23
- EGM
- 28-Oct-23
- 26-Sept-23
- POM
- 27-Oct-23
- 25-Sept-23
- POM
- 12-Aug-22
- 26-May-22
- AGM
- 06-Feb-22
- 05-Jan-22
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 24-May-24
- -
- 02-Aug-24
- 0.1
- 15-May-23
- -
- 27-Jul-23
- 3
- 01-Nov-22
- 17-Nov-22
- 16-Nov-22
- 1
- 26-May-22
- -
- 04-Aug-22
- 2
- 26-Oct-21
- 12-Nov-21
- 11-Nov-21
- 1
- Ex-Splits
- Old FV
- New FV
- Description
- 02-May-24
- 10
- 1
- Stock split from Rs. 10/- to Re. 1/-.
- Announced on
- Record Date
- Ex-Rights Date
- Ratio
- FV
- Premium
- Description
- 14-Dec-21
- 09-Apr-22
- 07-Apr-22
- 4:17
- 10
- 390
- Rights issue of equity shares of Rs. 10/- each in the ratio of 4:17 @ premium of Rs. 390/-